Table 2.

Relationship between survivin expression and HER-2/EGFR expression in breast cancer

Survivin-positive cases, n (%)
HER-2, EGFR0/5 (0)
HER-2, EGFR+3/5 (60)3/10 (30)
HER-2+, EGFR2/10 (20)38/53 (71.7)
HER-2+, EGFR+33/33 (100)35/43 (81.4)